Eukaryotic mRNAs are modified by several chemical marks which have significant impacts on mRNA biology, gene expression, and cellular metabolism as well as on the survival and development of the whole organism. The most abundant and well-studied mRNA base modifications are m6A and ADAR RNA editing. Recent studies have also identified additional mRNA marks such as m6Am, m5C, m1A and Ψ and studied their roles. Each type of modification is deposited by a specific writer, many types of modification are recognized and interpreted by several different readers and some types of modifications can be removed by eraser enzymes. Several works have addressed the functional relationships between some of the modifications. In this review we provide an overview on the current status of research on the different types of mRNA modifications and about the crosstalk between different marks and its functional consequences.

Central European Institute of Technology CEITEC Masaryk University Brno Brno Czech Republic

Zobrazit více v PubMed

Boccaletto P, Machnicka MA, Purta E, et al. MODOMICS: a database of RNA modification pathways. 2017 update. Nucleic Acids Res. 2018;46:D303–D7. PubMed PMC

Xu L, Seki M.. Recent advances in the detection of base modifications using the Nanopore sequencer. J Hum Genet. 2020;65:25–33. PubMed PMC

Hogg M, Paro S, Keegan LP, et al. RNA editing by mammalian ADARs. Adv Genet. 2011;73:87–120. PubMed

Zaccara S, Ries RJ, Jaffrey SR. Reading, writing and erasing mRNA methylation. Nat Rev Mol Cell Biol. 2019;20:608–624. PubMed

Licht K, Hartl M, Amman F, et al. Inosine induces context-dependent recoding and translational stalling. Nucleic Acids Res. 2019;47:3–14. PubMed PMC

Gallo A, Vukic D, Michalik D, et al. ADAR RNA editing in human disease; more to it than meets the I. Hum Genet. 2017;136:1265–1278. PubMed

Chen Z, Qi M, Shen B, et al. Transfer RNA demethylase ALKBH3 promotes cancer progression via induction of tRNA-derived small RNAs. Nucleic Acids Res. 2019;47:2533–2545. PubMed PMC

Fu Y, Dominissini D, Rechavi G, et al. Gene expression regulation mediated through reversible m(6)A RNA methylation. Nat Rev Genet. 2014;15:293–306. PubMed

Veliz EA, Easterwood LM, Beal PA. Substrate analogues for an RNA-editing adenosine deaminase: mechanistic investigation and inhibitor design. J Am Chem Soc. 2003;125:10867–10876. PubMed

Eggington JM, Greene T, Bass BL. Predicting sites of ADAR editing in double-stranded RNA. Nat Commun. 2011;2:319. PubMed PMC

Tan MH, Li Q, Shanmugam R, et al. Dynamic landscape and regulation of RNA editing in mammals. Nature. 2017;550:249–254. PubMed PMC

Batista PJ, Molinie B, Wang J, et al. m(6)A RNA modification controls cell fate transition in mammalian embryonic stem cells. Cell Stem Cell. 2014;15:707–719. PubMed PMC

Bazak L, Levanon EY, Eisenberg E. Genome-wide analysis of Alu editability. Nucleic Acids Res. 2014;42:6876–6884. PubMed PMC

Bazak L, Haviv A, Barak M, et al. A-to-I RNA editing occurs at over a hundred million genomic sites, located in a majority of human genes. Genome Res. 2014;24:365–376. PubMed PMC

Porath HT, Schaffer AA, Kaniewska P, et al. A-to-I RNA editing in the earliest-diverging eumetazoan phyla. Mol Biol Evol. 2017;34:1890–1901. PubMed PMC

Roundtree IA, Evans ME, Pan T, et al. Dynamic RNA modifications in gene expression regulation. Cell. 2017;169:1187–1200. PubMed PMC

Meng J, Lu Z, Liu H, et al. A protocol for RNA methylation differential analysis with MeRIP-Seq data and exomePeak R/bioconductor package. Methods. 2014;69:274–281. PubMed PMC

Chen K, Lu Z, Wang X, et al. High-resolution N(6) -methyladenosine (m(6) A) map using photo-crosslinking-assisted m(6) A sequencing. Angew Chem Int Ed Engl. 2015;54:1587–1590. PubMed PMC

Borchert GM, Gilmore BL, Spengler RM, et al. Adenosine deamination in human transcripts generates novel microRNA binding sites. Hum Mol Genet. 2009;18:4801–4807. PubMed PMC

Das Mandal S, Ray PS. Transcriptome-wide analysis reveals spatial correlation between N6-methyladenosine and binding sites of microRNAs and RNA-binding proteins. Genomics. 2021;113:205–216. PubMed

Roost C, Lynch SR, Batista PJ, et al. Structure and thermodynamics of N6-methyladenosine in RNA: a spring-loaded base modification. J Am Chem Soc. 2015;137:2107–2115. PubMed PMC

Bass BL, Weintraub H. A developmentally regulated activity that unwinds RNA duplexes. Cell. 1987;48:607–613. PubMed

Rebagliati MR, Melton DA. Antisense RNA injections in fertilized frog eggs reveal an RNA duplex unwinding activity. Cell. 1987;48:599–605. PubMed

Mauger DM, Cabral BJ, Presnyak V, et al. mRNA structure regulates protein expression through changes in functional half-life. Proc Nat Acad Sci. 2019;116:24075–24083. PubMed PMC

Xiang JF, Yang Q, Liu CX, et al. N(6)-methyladenosines modulate A-to-I RNA editing. Mol Cell. 2018;69:126–35 e6. PubMed

Chai RC, Wu F, Wang QX, et al. m(6)A RNA methylation regulators contribute to malignant progression and have clinical prognostic impact in gliomas. Aging (Albany NY). 2019;11:1204–1225. PubMed PMC

Wang W, Li J, Lin F, et al. Identification of N(6)-methyladenosine-related lncRNAs for patients with primary glioblastoma. Neurosurg Rev. 2021;44:463–470. PubMed

Li F, Yi Y, Miao Y, et al. N(6)-methyladenosine modulates nonsense-mediated mRNA decay in human glioblastoma. Cancer Res. 2019;79:5785–5798. PubMed PMC

Visvanathan A, Patil V, Abdulla S, et al. N(6)-methyladenosine landscape of glioma stem-like cells: METTL3 is essential for the expression of actively transcribed genes and sustenance of the oncogenic signaling. Genes (Basel). 2019;10:141. PubMed PMC

Tassinari V, Cesarini V, Tomaselli S, et al. ADAR1 is a new target of METTL3 and plays a pro-oncogenic role in glioblastoma by an editing-independent mechanism. Genome Biol. 2021;22:51. PubMed PMC

Heale BS, Keegan LP, McGurk L, et al. Editing independent effects of ADARs on the miRNA/siRNA pathways. Embo J. 2009;28:3145–3156. PubMed PMC

Kariko K, Buckstein M, Ni H, et al. Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity. 2005;23:165–175. PubMed

Hartner JC, Schmittwolf C, Kispert A, et al. Liver disintegration in the mouse embryo caused by deficiency in the RNA-editing enzyme ADAR1. J Biol Chem. 2004;279:4894–4902. PubMed

Wang Q, Miyakoda M, Yang W, et al. Stress-induced apoptosis associated with null mutation of ADAR1 RNA editing deaminase gene. J Biol Chem. 2004;279:4952–4961. PubMed

Mannion NM, Greenwood SM, Young R, et al. The RNA-editing enzyme ADAR1 controls innate immune responses to RNA. Cell Rep. 2014;9:1482–1494. PubMed PMC

Rice GI, Kasher PR, Forte GM, et al. Mutations in ADAR1 cause Aicardi-Goutieres syndrome associated with a type I interferon signature. Nat Genet. 2012;44:1243–1248. PubMed PMC

Liddicoat BJ, Piskol R, Chalk AM, et al. RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself. Science. 2015;349:1115–1120. PubMed PMC

Chung H, Calis JJA, Wu X, et al. Human ADAR1 prevents endogenous RNA from triggering translational shutdown. Cell. 2018;172:811–24.e14. PubMed PMC

Li Y, Banerjee S, Goldstein SA, et al. Ribonuclease L mediates the cell-lethal phenotype of double-stranded RNA editing enzyme ADAR1 deficiency in a human cell line. eLife. 2017;6:e25687. PubMed PMC

Quin J, Sedmik J, Vukic D, et al. ADAR RNA modifications, the epitranscriptome and innate immunity. Trends Biochem Sci. 2021;46(9):758–771. PubMed

Spackova N, Reblova K. Role of inosine(-)Uracil Base Pairs in the canonical RNA duplexes. Genes (Basel). 2018;9:324. PubMed PMC

Harland R, Weintraub H. Translation of mRNA injected into Xenopus oocytes is specifically inhibited by antisense RNA. J Cell Biol. 1985;101:1094–1099. PubMed PMC

Barak M, Porath HT, Finkelstein G, et al. Purifying selection of long dsRNA is the first line of defense against false activation of innate immunity. Genome Biol. 2020;21:26. PubMed PMC

Tang L, Wei X, Li T, et al. Emerging Perspectives of RNA N (6)-methyladenosine (m(6)A) modification on immunity and autoimmune diseases. Front Immunol. 2021;12:630358. PubMed PMC

Shulman Z, Stern-Ginossar N. The RNA modification N6-methyladenosine as a novel regulator of the immune system. Nat Immunol. 2020;21:501–512. PubMed

Lou X, Wang JJ, Wei YQ, et al. Emerging role of RNA modification N6-methyladenosine in immune evasion. Cell Death Dis. 2021;12:300. PubMed PMC

Chen J, Sun Y, Ou Z, et al. Androgen receptor-regulated circFNTA activates KRAS signaling to promote bladder cancer invasion. EMBO Rep. 2020;21:e48467. PubMed PMC

Lu M, Zhang Z, Xue M, et al. N(6)-methyladenosine modification enables viral RNA to escape recognition by RNA sensor RIG-I. Nat Microbiol. 2020;5:584–598. PubMed PMC

Jeck WR, Sorrentino JA, Wang K, et al. Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA. 2013;19:141–157. PubMed PMC

Rybak-Wolf A, Stottmeister C, Glazar P, et al. Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed. Mol Cell. 2015;58:870–885. PubMed

Chen YG, Chen R, Ahmad S, et al. N6-methyladenosine modification controls circular RNA immunity. Mol Cell. 2019;76:96–109 e9. PubMed PMC

Hartner JC, Walkley CR, Lu J, et al. ADAR1 is essential for maintenance of hematopoiesis and suppression of interferon signaling. Nat Immunol. 2009;10:109–115. PubMed PMC

Liddicoat BJ, Hartner JC, Piskol R, et al. Adenosine-to-inosine RNA editing by ADAR1 is essential for normal murine erythropoiesis. Exp Hematol. 2016;44:947–963. PubMed PMC

Gao Y, Vasic R, Song Y, et al. m(6)A modification prevents formation of endogenous double-stranded RNAs and deleterious innate immune responses during hematopoietic development. Immunity. 2020;52:1007–21 e8. PubMed PMC

Gambaryan AS, Venkstern TV, Bayev AA. On the mechanism of tRNA methylase-tRNA recognition. Nucleic Acids Res. 1976;3:2079–2087. PubMed PMC

Tang H, Fan X, Xing J, et al. NSun2 delays replicative senescence by repressing p27 (KIP1) translation and elevating CDK1 translation. Aging (Albany NY). 2015;7:1143–1158. PubMed PMC

Yang X, Yang Y, Sun B-F, et al. 5-methylcytosine promotes mRNA export — NSUN2 as the methyltransferase and ALYREF as an m5C reader. Cell Res. 2017;27(5):606–625. PubMed PMC

Hussain S, Sajini AA, Blanco S, et al. NSun2-mediated cytosine-5 methylation of vault noncoding RNA determines its processing into regulatory small RNAs. Cell Rep. 2013;4:255–261. PubMed PMC

Bohnsack KE, Hobartner C, Bohnsack MT. Eukaryotic 5-methylcytosine (m(5)C) RNA methyltransferases: mechanisms, cellular functions, and links to disease. Genes (Basel). 2019;10:102. PubMed PMC

Squires JE, Patel HR, Nousch M, et al. Widespread occurrence of 5-methylcytosine in human coding and non-coding RNA. Nucleic Acids Res. 2012;40:5023–5033. PubMed PMC

Li Q, Li X, Tang H, et al. NSUN2-mediated m5C methylation and METTL3/METTL14-mediated m6A methylation cooperatively enhance p21 translation. J Cell Biochem. 2017;118:2587–2598. PubMed PMC

Dai X, Gonzalez G, Li L, et al. YTHDF2 binds to 5-methylcytosine in RNA and modulates the maturation of ribosomal RNA. Anal Chem. 2020;92:1346–1354. PubMed PMC

Zheng G, Dahl JA, Niu Y, et al. ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility. Mol Cell. 2013;49:18–29. PubMed PMC

Dominissini D, Nachtergaele S, Moshitch-Moshkovitz S, et al. The dynamic N(1)-methyladenosine methylome in eukaryotic messenger RNA. Nature. 2016;530:441–446. PubMed PMC

Safra M, Sas-Chen A, Nir R, et al. The m1A landscape on cytosolic and mitochondrial mRNA at single-base resolution. Nature. 2017;551:251–255. PubMed

Dominissini D, Moshitch-Moshkovitz S, Salmon-Divon M, et al. Transcriptome-wide mapping of N(6)-methyladenosine by m(6) A-seqbased on immunocapturing and massively parallel sequencing. Nat Protoc. 2013;8:176–189. PubMed

Peifer C, Sharma S, Watzinger P, et al. Yeast Rrp8p, a novel methyltransferase responsible for m1A 645 base modification of 25S rRNA. Nucleic Acids Res. 2013;41:1151–1163. PubMed PMC

Sharma S, Lafontaine DLJ. ‘View From A Bridge’: a new perspective on eukaryotic rRNA base modification. Trends Biochem Sci. 2015;40:560–575. PubMed

RajBhandary UL, Stuart A, Faulkner RD, et al. Nucleotide sequence studies on yeast phenylalanine sRNA. Cold Spring Harb Symp Quant Biol. 1966;31:425–434. PubMed

Pan T. Modifications and functional genomics of human transfer RNA. Cell Res. 2018;28:395–404. PubMed PMC

Sharma S, Hartmann JD, Watzinger P, et al. A single N(1)-methyladenosine on the large ribosomal subunit rRNA impacts locally its structure and the translation of key metabolic enzymes. Sci Rep. 2018;8:11904. PubMed PMC

Dai X, Wang T, Gonzalez G, et al. Identification of YTH domain-containing proteins as the readers for N1-methyladenosine in RNA. Anal Chem. 2018;90:6380–6384. PubMed PMC

Lao N, Barron N. Cross-talk between m6A and m1A regulators, YTHDF2 and ALKBH3 fine-tunes mRNA expression. bioRxiv. 2019. 10.1101/589747. DOI

Khoddami V, Yerra A, Mosbruger TL, et al. Transcriptome-wide profiling of multiple RNA modifications simultaneously at single-base resolution. Proc Natl Acad Sci U S A. 2019;116:6784–6789. PubMed PMC

Wei J, Liu F, Lu Z, et al. Differential m(6)A, m(6)Am, and m(1)A demethylation mediated by FTO in the cell nucleus and cytoplasm. Mol Cell. 2018;71:973–85 e5. PubMed PMC

Ma CJ, Ding JH, Ye TT, Yuan BF, Feng YQ. AlkB homologue 1 demethylates N(3)-methylcytidine in mRNA of mammals. ACS Chem Biol. 2019;14:1418–1425. PubMed

Liu F, Clark W, Luo G, et al. ALKBH1-mediated tRNA demethylation regulates translation. Cell. 2016;167:816–28 e16. PubMed PMC

Westbye MP, Feyzi E, Aas PA, et al. Human AlkB homolog 1 is a mitochondrial protein that demethylates 3-methylcytosine in DNA and RNA. J Biol Chem. 2008;283:25046–25056. PubMed PMC

Ueda Y, Ooshio I, Fusamae Y, et al. AlkB homolog 3-mediated tRNA demethylation promotes protein synthesis in cancer cells. Sci Rep. 2017;7:42271. PubMed PMC

Wei C, Gershowitz A, Moss B. N6, O2ʹ-dimethyladenosine a novel methylated ribonucleoside next to the 5ʹ terminal of animal cell and virus mRNAs. Nature. 1975;257:251–253. PubMed

Akichika S, Hirano S, Shichino Y, et al. Cap-specific terminal N (6)-methylation of RNA by an RNA polymerase II-associated methyltransferase. Science. 2019;363:eaav0080. PubMed

Mauer J, Sindelar M, Despic V, et al. FTO controls reversible m(6)Am RNA methylation during snRNA biogenesis. Nat Chem Biol. 2019;15:340–347. PubMed PMC

Fan H, Sakuraba K, Komuro A, et al. PCIF1, a novel human WW domain-containing protein, interacts with the phosphorylated RNA polymerase II. Biochem Biophys Res Commun. 2003;301:378–385. PubMed

Boulias K, Toczydlowska-Socha D, Hawley BR, et al. Identification of the m(6)Am methyltransferase PCIF1 reveals the location and functions of m(6)Am in the transcriptome. Mol Cell. 2019;75:631–43 e8. PubMed PMC

Darnell RB, Ke S, Darnell JE Jr. Pre-mRNA processing includes N6 methylation of adenosine residues that are retained in mRNA exons and the fallacy of “RNA epigenetics”. RNA. 2018;24:262–267. PubMed PMC

Ke S, Pandya-Jones A, Saito Y, et al. m(6)A mRNA modifications are deposited in nascent pre-mRNA and are not required for splicing but do specify cytoplasmic turnover. Genes Dev. 2017;31:990–1006. PubMed PMC

Covelo-Molares H, Bartosovic M, Vanacova S. RNA methylation in nuclear pre-mRNA processing. Wiley Interdiscip Rev RNA. 2018;9:e1489. PubMed PMC

Xiao W, Adhikari S, Dahal U, et al. Nuclear m(6)A reader YTHDC1 regulates mRNA splicing. Mol Cell. 2016;61:507–519. PubMed

Kasowitz SD, Ma J, Anderson SJ, et al. Nuclear m6A reader YTHDC1 regulates alternative polyadenylation and splicing during mouse oocyte development. Plos Genet. 2018;14:e1007412. PubMed PMC

Bartosovic M, Molares HC, Gregorova P, et al. N6-methyladenosine demethylase FTO targets pre-mRNAs and regulates alternative splicing and 3ʹ-end processing. Nucleic Acids Res. 2017;45:11356–11370. PubMed PMC

Tang C, Klukovich R, Peng H, et al. ALKBH5-dependent m6A demethylation controls splicing and stability of long 3ʹ-UTR mRNAs in male germ cells. Proc Natl Acad Sci U S A. 2018;115:E325–E33. PubMed PMC

Chen H, Gu L, Orellana EA, et al. METTL4 is an snRNA m(6)Am methyltransferase that regulates RNA splicing. Cell Res. 2020;30:544–547. PubMed PMC

Goh YT, Koh CWQ, Sim DY, et al. METTL4 catalyzes m6Am methylation in U2 snRNA to regulate pre-mRNA splicing. Nucleic Acids Res. 2020;48:9250–9261. PubMed PMC

Mendel M, Delaney K, Pandey RR, et al. Splice site m(6)A methylation prevents binding of U2AF35 to inhibit RNA splicing. Cell. 2021;184:3125–42 e25. PubMed PMC

Chao Y, Jiang Y, Zhong M, et al. Regulatory roles and mechanisms of alternative RNA splicing in adipogenesis and human metabolic health. Cell Biosci. 2021;11:66. PubMed PMC

Warda AS, Kretschmer J, Hackert P, et al. Human METTL16 is a N(6)-methyladenosine (m(6)A) methyltransferase that targets pre-mRNAs and various non-coding RNAs. EMBO Rep. 2017;18:2004–2014. PubMed PMC

Lee Y, Choe J, Park OH, et al. Molecular mechanisms driving mRNA degradation by m(6)A modification. Trends Genet. 2020;36:177–188. PubMed

Mauer J, Luo X, Blanjoie A, et al. Reversible methylation of m(6)Am in the 5ʹ cap controls mRNA stability. Nature. 2017;541:371–375. PubMed PMC

Sendinc E, Valle-Garcia D, Dhall A, et al. PCIF1 catalyzes m6Am mRNA methylation to regulate gene expression. Mol Cell. 2019;75:620–30 e9. PubMed PMC

Wang F, Liao Y, Zhang M, et al. N6-methyladenosine demethyltransferase FTO-mediated autophagy in malignant development of oral squamous cell carcinoma. Oncogene. 2021;40:3885–3898. PubMed

Relier S, Ripoll J, Guillorit H, et al. FTO-mediated cytoplasmic m(6)Am demethylation adjusts stem-like properties in colorectal cancer cell. Nat Commun. 2021;12:1716. PubMed PMC

Charette M, Gray MW. Pseudouridine in RNA: what, where, how, and why. IUBMB Life. 2000;49:341–351. PubMed

Carlile TM, Rojas-Duran MF, Zinshteyn B, et al. Pseudouridine profiling reveals regulated mRNA pseudouridylation in yeast and human cells. Nature. 2014;515:143–146. PubMed PMC

Schwartz S, Bernstein DA, Mumbach MR, et al. Transcriptome-wide mapping reveals widespread dynamic-regulated pseudouridylation of ncRNA and mRNA. Cell. 2014;159:148–162. PubMed PMC

Warren L, Manos PD, Ahfeldt T, et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell. 2010;7:618–630. PubMed PMC

Andries O, Mc Cafferty S, De Smedt SC, et al. N(1)-methylpseudouridine-incorporated mRNA outperforms pseudouridine-incorporated mRNA by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and mice. J Control Release. 2015;217:337–344. PubMed